Proteomics analysis of siRNA-mediated silencing of Wilms' tumor 1 in the MDA-MB-468 breast cancer cell line

Chesor,Musleeha; Roytrakul,Sittiruk; Graidist,Potchanapond; Kanokwiroon,Kanyanatt

doi:10.3892/or.2014.3013

Proteomics analysis of siRNA-mediated silencing of Wilms' tumor 1 in the MDA-MB-468 breast cancer cell line

Authors:
- Musleeha Chesor
- Sittiruk Roytrakul
- Potchanapond Graidist
- Kanyanatt Kanokwiroon
View Affiliations

Affiliations: Programme of Biomedical Sciences, Department of Biomedical Sciences, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani 12120, Thailand, Department of Biomedical Sciences, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand
Published online on: February 5, 2014 https://doi.org/10.3892/or.2014.3013
Pages: 1754-1760

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The Wilms' tumor 1 (WT1) gene encodes a zinc finger which appears to be a transcriptional activator or repressor for many genes involved in cell differentiation, growth and apoptosis. In order to determine the relationship between WT1 and related proteins, WT1 was silenced with small interfering RNA (siRNA) and the protein expression pattern was analyzed by proteomics analysis including one-dimensional gel electrophoresis (1-DE) and LC-MS/MS mass spectrometry. The results revealed that 14 proteins were expressed in WT1-silenced cells (siRNAWT1) and 12 proteins were expressed in the WT1-expressing cells (siRNAneg), respectively. These proteins may be classified by their functions in apoptosis, cell signaling, protein folding, gene expression, redox-regulation, transport, structural and unknown functions. Mitogaligin, an apoptosis-related molecule, was identified when WT1 was silenced while the proteins related to the signaling pathway were detected in both siRNAneg and siRNAWT1 but the type of proteins were different. For example, the IBtK protein and the SH2 domain-containing protein were present in siRNAWT1 conditions, while the platelet-derived growth factor receptor α (PDGFRA) and Rho guanine nucleotide exchange factor 1 (Rho-GEF 1) were expressed in siRNAneg. Of these, Rho-GEF was selected for validation by western blot analysis and demonstrated to be present only in the presence of WT1. In conclusion, WT1 is related to mitogaligin via EGFR and behaves as an anti-apoptotic molecule. Moreover, WT1 may be associated with PDGFRA and Rho-GEF 1 that activates proliferation in MDA-MB-468 cells.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Adami HO, Signorello LB and Trichopoulos D: Towards an understanding of breast cancer etiology. Semin Cancer Biol. 8:255–262. 1998. View Article : Google Scholar : PubMed/NCBI
3	Dumitrescu R and Cotarla I: Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med. 9:208–221. 2005. View Article : Google Scholar : PubMed/NCBI
4	Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH and Bruns GA: Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 343:774–778. 1990. View Article : Google Scholar : PubMed/NCBI
5	Haber DA, Park S, Maheswaran S, et al: WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant. Science. 262:2057–2059. 1993. View Article : Google Scholar : PubMed/NCBI
6	Loeb DM, Evron E, Patel CB, et al: Wilms’ tumor suppressor gene (WT1) is expressed in primary breast tumor despite tumor-specific promoter methylation. Cancer Res. 61:921–925. 2001.
7	Navakanit R, Graidist P, Leeanansaksiri W and Dechsukum C: Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilm tumor 1 gene. J Med Assoc Thai. 90:2416–2421. 2007.PubMed/NCBI
8	Miyoshi Y, Ando A, Egawa C, et al: High expression of Wilms’ tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res. 8:1167–1171. 2002.
9	Oji Y, Miyoshi Y, Kiyotoh E, et al: Absence of mutations in the Wilms’ tumor gene WT1 in primary breast cancer. Jpn J Clin Oncol. 34:74–77. 2004.
10	Yang L, Han Y, Saurez Saiz F and Minden M: A tumor suppressor and oncogene: the WT1 story. Leukemia. 21:868–876. 2007.PubMed/NCBI
11	Graidist P: The role of WT1 in breast and other cancers: oncogene or tumor suppressor gene? Songkla Med J. 27:435–449. 2009.
12	Subik K, Lee JF, Baxter L, et al: The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer. 4:35–41. 2010.PubMed/NCBI
13	Filmus J, Pollak MN, Cailleau R and Buick RN: MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun. 128:898–905. 1985. View Article : Google Scholar
14	Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y, Buckley JA, Isaacs JT and Davidson NE: Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res. 54:5280–5283. 1994.PubMed/NCBI
15	Holiday LD and Speirs V: Choosing the right cell line for breast cancer research. Breast Cancer Res. 13:2152011. View Article : Google Scholar : PubMed/NCBI
16	Guittaut M, Charpentier S, Normand M, Dubois J, Raimond J and Legrand A: Identification of an internal gene to the human Galectin-3 gene with two different overlapping reading frames that do not encode Galectin-3. J Biol Chem. 276:2652–2657. 2001. View Article : Google Scholar : PubMed/NCBI
17	Duneau M, Boyer-Guittaut P, Gonzalez P, et al: Galig, a novel cell death gene that encodes a mitochondrial protein promoting cytochrome c release. Exp Cell Res. 302:194–205. 2005. View Article : Google Scholar
18	Robinet O, Mollet L, Gonzalez P, Normand T, Charpentier S, Brulé F, et al: The mitogaligin protein is addressed to the nucleus via a non-classical localization signal. Biochem Biophys Res Commun. 392:53–57. 2010. View Article : Google Scholar : PubMed/NCBI
19	Yu K, Toral-Barza L, Discafani C, Zhang WG, Skotnicki J, Frost P and Gibbons JJ: mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer. 8:249–258. 2001. View Article : Google Scholar : PubMed/NCBI
20	Zhou H and Huang S: mTOR signaling in cancer cell motility and tumor metastasis. Crit Rev Eukaryot Gene Expr. 20:1–16. 2010. View Article : Google Scholar : PubMed/NCBI
21	Razmara M, Heldin CH and Lennartsson J: Platelet-derived growth factor-induced Akt phosphorylation requires mTOR/Rictor and phospholipase C-γ1, whereas S6 phosphorylation depends on mTOR/Raptor and phospholipase D. Cell Commun Signal. 11:32013.PubMed/NCBI
22	Bruening W, Moffett P, Chia S, Heinrich G and Pelletier J: Identification of nuclear localization signals within the zinc fingers of the WT1 tumor suppressor gene product. FEBS Lett. 393:41–47. 1996. View Article : Google Scholar : PubMed/NCBI
23	Silberstein GB, Van Horn K, Strickland P, Roberts CT Jr and Daniel CW: Altered expression of WT1 Wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci USA. 94:8132–8137. 1997. View Article : Google Scholar : PubMed/NCBI
24	Niksic M, Slight J, Sanford JR, Caceres FJ and Hastie ND: The Wilms’ tumor protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet. 13:464–471. 2004.
25	Alberts B, Johnson A, Lewis J, Raff M, Roberts K and Walter P: Molecular Biology of the Cell. 5th edition. Garland Science; New York: 2008
26	Shang X, Marchioni F, Evelyn CR, et al: Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors. Proc Natl Acad Sci USA. 110:3155–3160. 2013. View Article : Google Scholar : PubMed/NCBI
27	Janda E, Palmieri C, Pisano A, Pontoriero M, Laccino E, Falcone C, et al: Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ. Blood. 117:6520–6531. 2011.PubMed/NCBI